Stellar Biotech Inc (SBOTF) 1.0299 $SBOTF
Stellar Biotechnologies Reports First Quarter 2015 Financial Results
Marketwired - Mon Feb 09, 7:30AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, announced financial results for the first quarter period ended December 31, 2014.
KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies to Present at Biotech Showcase(TM) 2015 Conference
Marketwired - Thu Jan 08, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that the Company's management team will present at the 7th Annual Biotech Showcase 2015 conference, being held at the Parc 55 Wyndham Hotel in San Francisco, CA, on Tuesday, January 13 at 2:30 p.m. PST.
KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies to Present at LD Micro Conference
Marketwired - Mon Nov 24, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today the Company's management team will present at the upcoming LD Micro Conference on Tuesday, December 2 at 1:00 p.m. PST.
KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies misses by $0.03, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:55AM CST
Stellar Biotechnologies Reports Year-End 2014 Financial Results
Marketwired - Thu Nov 13, 9:17AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, has reported preliminary financial results for the year ended August 31, 2014.
KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies and Araclon Biotech Sign Exclusive KLH Supply Agreement for Clinical Trials in Alzheimer's Active Immunotherapies
Marketwired - Tue Nov 11, 11:46AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) and Araclon Biotech SL ("Araclon" today announced that the companies have executed a definitive exclusive supply agreement to meet Araclon's Phase (II and III) clinical trial requirements for Keyhole Limpet Hemocyanin (KLH) used in Araclon's active immunotherapies against Alzheimer's disease.
KLH.VN: 1.280 (-0.030)
Stellar Bio tech chief bids adieu
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 3:05PM CST
Stellar Biotechnologies Announces Resignation of CTO Effective December 10, 2014
Marketwired - Fri Nov 07, 12:30PM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), today announced the resignation of chief technology officer Herbert Chow, Ph.D. He will be leaving the company on December 10, 2014 for personal reasons. Dr. Chow's responsibilities will be reassigned based on a mutually agreed transitional plan.
KLH.VN: 1.280 (-0.030)
Stellar Bio reports November 13
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:52AM CST
Stellar Biotechnologies Announces Year-End 2014 Conference Call
Marketwired - Thu Nov 06, 7:32AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , will host its year-end 2014 conference call and webcast at 1:30 PM ET (10:30 AM PT) on November 13, 2014.
KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies and Biovest International Sign KLH Supply Agreement for BiovaxID Immunotherapy for Follicular Non-Hodgkin's Lymphoma
Marketwired - Thu Oct 23, 1:16PM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) and Biovest International, Inc. ("Biovest" today announced that the companies have executed a definitive supply agreement to meet Biovest's requirements for Keyhole Limpet Hemocyanin (KLH) for use in Biovest's BiovaxID(R) active immunotherapy to treat follicular non-Hodgkin's lymphoma.
KLH.VN: 1.280 (-0.030)
Market Maker Surveillance Report. INS, VOXX, CNET, GTI, ATOS, SBOTF, Losing Stocks With Lowest Price Friction For Tuesday, September 23rd 2014
M2 - Wed Sep 24, 3:42AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4582 companies with "abnormal" market making, 1424 companies with positive Friction Factors and 3854 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Intelligent Systems Corp (NYSE:INS), VOXX INTERNATIONAL CORP (NASDAQ:VOXX), Chinanet Online Holdings Inc (NASDAQ:CNET), Graftech International Ltd (NYSE:GTI), AUTOMATED SVCS INC (:ATOS), STLG BIOTECH REG S (OTC:SBOTF). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
VOXX: 8.85 (+0.10), INS: 2.10 (unch), GTI: 4.16 (+0.32), CNET: 1.58 (+0.02)
Stellar Biotechnologies Analyst Report; Early Mover in Fast Growing Immunotherapy Market by BrokerBank Securities, Inc.
PR Newswire - Fri Sep 05, 6:30AM CDT
Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is an emerging contender in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, and infectious diseases) as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology.
Market Maker Surveillance Report. TCCO, BTH, PRLS, SBOTF, SGOC, INFI, Winning Stocks With Lowest Price Friction For Wednesday, September 3rd 2014
M2 - Thu Sep 04, 10:03AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4918 companies with "abnormal" market making, 2306 companies with positive Friction Factors and 2830 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Technical Communications Corp (NASDAQ:TCCO), Blyth Inc (NYSE:BTH), Peerless Systems Corp (NASDAQ
RLS), STLG BIOTECH REG S (OTC:SBOTF), SOLOMON GOLD CORP (NASDAQ:SGOC), Infinity Pharmaceuticals Inc (NASDAQ:INFI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
BTH: 7.99 (-0.17), PRLS: 6.96 (-0.02), SGOC: 0.56 (-0.03), INFI: 15.13 (+0.55), TCCO: 4.32 (-0.07)
Stellar Biotechnologies to Present at Rodman & Renshaw Global Investment Conference
Marketwire - Tue Sep 02, 11:03AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oakes, the Company's President and CEO, will present at the upcoming Rodman & Renshaw 2014 Global Investment Conference, on Tuesday, September 9, 2014 at 1:15PM ET.
KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies Reports on Unusual Trading Activity
Marketwire - Fri Aug 29, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH) reports that, in view of the unusual market trading activity in the Company's stock, the Investment Industry Regulatory Organization of Canada (IIROC) has contacted the Company in accordance with its usual market surveillance practice.
KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies Reports Third Quarter 2014 Financial Results and Recent Corporate Developments
Marketwire - Thu Jul 10, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company" (OTCQB: SBOTF) (TSX VENTURE: KLH), a leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets, has reported financial results for the third quarter and nine months ended May 31, 2014, and provided operational highlights.
KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies Reports First Quarter 2015 Financial Results
Marketwired - Mon Feb 09, 7:30AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, announced financial results for the first quarter period ended December 31, 2014. KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies to Present at Biotech Showcase(TM) 2015 Conference
Marketwired - Thu Jan 08, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that the Company's management team will present at the 7th Annual Biotech Showcase 2015 conference, being held at the Parc 55 Wyndham Hotel in San Francisco, CA, on Tuesday, January 13 at 2:30 p.m. PST. KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies to Present at LD Micro Conference
Marketwired - Mon Nov 24, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH) announced today the Company's management team will present at the upcoming LD Micro Conference on Tuesday, December 2 at 1:00 p.m. PST. KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies misses by $0.03, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:55AM CST
Stellar Biotechnologies Reports Year-End 2014 Financial Results
Marketwired - Thu Nov 13, 9:17AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, has reported preliminary financial results for the year ended August 31, 2014. KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies and Araclon Biotech Sign Exclusive KLH Supply Agreement for Clinical Trials in Alzheimer's Active Immunotherapies
Marketwired - Tue Nov 11, 11:46AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH) and Araclon Biotech SL ("Araclon" today announced that the companies have executed a definitive exclusive supply agreement to meet Araclon's Phase (II and III) clinical trial requirements for Keyhole Limpet Hemocyanin (KLH) used in Araclon's active immunotherapies against Alzheimer's disease. KLH.VN: 1.280 (-0.030)
Stellar Bio tech chief bids adieu
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 3:05PM CST
Stellar Biotechnologies Announces Resignation of CTO Effective December 10, 2014
Marketwired - Fri Nov 07, 12:30PM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH), today announced the resignation of chief technology officer Herbert Chow, Ph.D. He will be leaving the company on December 10, 2014 for personal reasons. Dr. Chow's responsibilities will be reassigned based on a mutually agreed transitional plan. KLH.VN: 1.280 (-0.030)
Stellar Bio reports November 13
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:52AM CST
Stellar Biotechnologies Announces Year-End 2014 Conference Call
Marketwired - Thu Nov 06, 7:32AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH" , will host its year-end 2014 conference call and webcast at 1:30 PM ET (10:30 AM PT) on November 13, 2014. KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies and Biovest International Sign KLH Supply Agreement for BiovaxID Immunotherapy for Follicular Non-Hodgkin's Lymphoma
Marketwired - Thu Oct 23, 1:16PM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH) and Biovest International, Inc. ("Biovest" today announced that the companies have executed a definitive supply agreement to meet Biovest's requirements for Keyhole Limpet Hemocyanin (KLH) for use in Biovest's BiovaxID(R) active immunotherapy to treat follicular non-Hodgkin's lymphoma. KLH.VN: 1.280 (-0.030)
Market Maker Surveillance Report. INS, VOXX, CNET, GTI, ATOS, SBOTF, Losing Stocks With Lowest Price Friction For Tuesday, September 23rd 2014
M2 - Wed Sep 24, 3:42AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4582 companies with "abnormal" market making, 1424 companies with positive Friction Factors and 3854 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Intelligent Systems Corp (NYSE:INS), VOXX INTERNATIONAL CORP (NASDAQ:VOXX), Chinanet Online Holdings Inc (NASDAQ:CNET), Graftech International Ltd (NYSE:GTI), AUTOMATED SVCS INC (:ATOS), STLG BIOTECH REG S (OTC:SBOTF). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
VOXX: 8.85 (+0.10), INS: 2.10 (unch), GTI: 4.16 (+0.32), CNET: 1.58 (+0.02)
Stellar Biotechnologies Analyst Report; Early Mover in Fast Growing Immunotherapy Market by BrokerBank Securities, Inc.
PR Newswire - Fri Sep 05, 6:30AM CDT
Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is an emerging contender in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, and infectious diseases) as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology.
Market Maker Surveillance Report. TCCO, BTH, PRLS, SBOTF, SGOC, INFI, Winning Stocks With Lowest Price Friction For Wednesday, September 3rd 2014
M2 - Thu Sep 04, 10:03AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 4918 companies with "abnormal" market making, 2306 companies with positive Friction Factors and 2830 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Technical Communications Corp (NASDAQ:TCCO), Blyth Inc (NYSE:BTH), Peerless Systems Corp (NASDAQ
RLS), STLG BIOTECH REG S (OTC:SBOTF), SOLOMON GOLD CORP (NASDAQ:SGOC), Infinity Pharmaceuticals Inc (NASDAQ:INFI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . BTH: 7.99 (-0.17), PRLS: 6.96 (-0.02), SGOC: 0.56 (-0.03), INFI: 15.13 (+0.55), TCCO: 4.32 (-0.07)
Stellar Biotechnologies to Present at Rodman & Renshaw Global Investment Conference
Marketwire - Tue Sep 02, 11:03AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oakes, the Company's President and CEO, will present at the upcoming Rodman & Renshaw 2014 Global Investment Conference, on Tuesday, September 9, 2014 at 1:15PM ET. KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies Reports on Unusual Trading Activity
Marketwire - Fri Aug 29, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH) reports that, in view of the unusual market trading activity in the Company's stock, the Investment Industry Regulatory Organization of Canada (IIROC) has contacted the Company in accordance with its usual market surveillance practice. KLH.VN: 1.280 (-0.030)
Stellar Biotechnologies Reports Third Quarter 2014 Financial Results and Recent Corporate Developments
Marketwire - Thu Jul 10, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"
(OTCQB: SBOTF) (TSX VENTURE: KLH), a leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets, has reported financial results for the third quarter and nine months ended May 31, 2014, and provided operational highlights. KLH.VN: 1.280 (-0.030)
